Eli Lilly's Cymbalta gets FDA nod for pain | Reuters

Links shared publicly online about this topic.

  • 750
    total visits

Eli Lilly's Cymbalta gets FDA nod for pain | Reuters

reuters.com

NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulators approved the use of Cymbalta, its blockbuster anti-depressant drug, for chronic musculoskeletal pain, including lower back pain and osteoarthritis.The

View full resource at reuters.com

Tags: Pain, Anxiety Medication, Antidepressant, Fibromyalgia Medication, Neuropathic Pain Medication, FDA, Cymbalta, Eli Lilly and Company

  • Share

Most Recently Shared on November 5, 2010 at 3:30 am By:

Bradmed Brad Lipson, DO

Eli Lilly's Cymbalta gets FDA nod for pain: NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulator... http://tinyurl.com/27cxlnk

2 years ago...

Eli Lilly's Cymbalta gets FDA nod for pain | Reuters

reuters.com — “NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulators approved the use of Cymbalta, its blockbuster anti-depressant drug, for chronic musculoskeletal pain, including lower back pain and osteoarthritis. TheView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on November 5, 2010 at 3:00 am By:

Advertisement